EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Adverse Pregnancy Outcomes in Sjogren's Disease Compared to Controls: An Interdisciplinary Approach with Maternal–Fetal Medicine

Lauren Tesoriero, Jennifer Kidd, Julie Piccione, Peter Izmirly, Meredith Akerman, Steven Carsons, Patricia Rekawek iD, Julie Nusbaum

American Journal of Perinatology Reports · 01.04.2025 · 15 (02) · e47-e52

DOI: 10.1055/a-2562-1643 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Perinatology Reports, erschienen am 01.04.2025. Verfasst von Lauren Tesoriero und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Internal Medicine, NYU Langone Hospital, Long Island, Mineola, New York. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Outside of the association of SS-A antibody with congenital heart block, little is known about adverse maternal and neonatal outcomes, in patients with Sjogren's disease (SjD). Our study involved collaboration with maternal–fetal medicine (MFM). A retrospective cohort study of pregnant patients: SjD patients were matched 1:3 with non-SjD controls. SjD patients were included by meeting the 2016 ACR/EULAR Criteria or by a rheumatologist diagnosis. Exclusion criteria were concurrent autoimmune disease or related antibodies. A composite of grouped outcomes was utilized and verified by MFM specialists. The primary outcome was adverse pregnancy outcome (APO) between the two groups. Statistical analysis was performed using a two-sample t-test and Fisher's exact test. 48 patients were included: 12 SjD patients and 36 controls. APO was significantly increased in SjD with one preterm birth, one fetal growth restriction, and one limb anomaly; non-SjD had one cardiac anomaly. There were no cases of CHB. SjD patients were more likely to be delivered by cesarean delivery. There was an increased risk of APO in SjD patients compared with controls. No significant difference in neonatal outcomes was found. We speculate that placental pathology may play a role in pathophysiology and future studies should be performed.

Schlagwörter

Stichwörter der Autor:innen

SS-ASS-B antibodiesSjogren's diseaseadverse pregnancy outcomesautoimmune disease

Autor:innen und Institutionen

  • Division of Rheumatology, Department of Internal Medicine, NYU Langone Hospital, Long Island, Mineola, New York.
  • NYU Long Island School of Medicine, Mineola, New York.
  • Northwell Health New Hyde Park, New York.
  • Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Uniondale, Uniondale, New York.
  • Department of Obstetrics and Gynecology, Long Island Jewish Medical Center, New Hyde Park, New York.
  • Division of Rheumatology, NYU Langone Health, New York, New York.

ORCID-Profile: Patricia Rekawek

Zitieren

APA

Tesoriero, L., Kidd, J., Piccione, J., Izmirly, P., Akerman, M., Carsons, S., Rekawek, P., & Nusbaum, J. (2025). Adverse Pregnancy Outcomes in Sjogren's Disease Compared to Controls: An Interdisciplinary Approach with Maternal–Fetal Medicine. American Journal of Perinatology Reports, 15(02), e47-e52. https://doi.org/10.1055/a-2562-1643

Vancouver

Tesoriero L, Kidd J, Piccione J, Izmirly P, Akerman M, Carsons S, et al. Adverse Pregnancy Outcomes in Sjogren's Disease Compared to Controls: An Interdisciplinary Approach with Maternal–Fetal Medicine. American Journal of Perinatology Reports. 2025;15(02):e47-e52. doi:10.1055/a-2562-1643

BibTeX
@article{Tesoriero2025,
  author = {Tesoriero, Lauren and Kidd, Jennifer and Piccione, Julie and Izmirly, Peter and Akerman, Meredith and Carsons, Steven and Rekawek, Patricia and Nusbaum, Julie},
  title = {Adverse Pregnancy Outcomes in Sjogren's Disease Compared to Controls: An Interdisciplinary Approach with Maternal–Fetal Medicine},
  journal = {American Journal of Perinatology Reports},
  year = {2025},
  volume = {15},
  number = {02},
  pages = {e47--e52},
  doi = {10.1055/a-2562-1643}
}
Kostenlos starten →